Therabiol Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Therabiol General Information

Description

Operator of a biopharmaceutical company intended to develop novel therapies against infectious diseases caused by agents such as Human Immunodeficiency Virus. The company's services mainly focus on developing safe and effective antibody therapies for the prevention, treatment, and cure of HIV infection, enabling patients to get access to better treatment options.

Contact Information

Website
www.therabiol.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 475 Brannan Street
  • Suite 220
  • San Francisco, CA 94107
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 475 Brannan Street
  • Suite 220
  • San Francisco, CA 94107
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therabiol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 11-Sep-2019 Completed Out of Business
4. Accelerator/Incubator Completed Product Development
3. Accelerator/Incubator 01-Jan-2014 Completed Product Development
2. Angel (individual) 08-Oct-2012 $150K $150K Completed Product Development
1. Accelerator/Incubator 01-May-2012 Completed Product Development
To view Therabiol’s complete valuation and funding history, request access »

Therabiol Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Therabiol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019201405-A1 Hiv anitgens and antibodies Inactive 28-Feb-2013
US-20160002319-A1 Hiv antigens and antibodies Inactive 28-Feb-2013
AU-2014224049-B2 Hiv antigens and antibodies Active 28-Feb-2013
AU-2014224049-A1 Hiv antigens and antibodies Active 28-Feb-2013 C07K16/1063

Ready to get started?

Request a free trial

Therabiol FAQs

  • When was Therabiol founded?

    Therabiol was founded in 2012.

  • Who is the founder of Therabiol?

    Girish Vyas Ph.D is the founder of Therabiol.

  • Where is Therabiol headquartered?

    Therabiol is headquartered in San Francisco, CA.

  • What industry is Therabiol in?

    Therabiol’s primary industry is Biotechnology.

  • Is Therabiol a private or public company?

    Therabiol is a Private company.

  • What is Therabiol’s current revenue?

    The current revenue for Therabiol is .

  • How much funding has Therabiol raised over time?

    Therabiol has raised $150K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »